Navigation Links
invivodata Recognized as One of Pittsburgh's Fastest Growing Private Companies
Date:8/25/2008

Pittsburgh Business Times Names invivodata to 2008 Pittsburgh 100

PITTSBURGH, Aug. 25 /PRNewswire/ -- invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that the Pittsburgh Business Times has recognized the company in the "2008 Pittsburgh 100" annual ranking of the fastest-growing, privately-held companies in Western Pennsylvania.

"We see the Pittsburgh 100 as one of the most important lists we publish," said Alan Robertson, publisher of the Pittsburgh Business Times. "The companies on this list represent many industries and many geographic locations around the region. The Pittsburgh 100 companies also represent all different sizes of companies, from small firms to multi-billion dollar operations. We see the Pittsburgh 100 as proof that the region remains a vibrant, growth-oriented business environment."

Rankings on the list were based on the rate of growth from 2005 through 2007. Honored at an awards program at the Duquesne Club in downtown Pittsburgh on August 21, invivodata was ranked the 10th fastest-growing technology company and #43 overall on the list of 100, based on revenue growth.

"We're very proud to be included in the Pittsburgh 100," said Doug Engfer, invivodata president and CEO. "We believe our inclusion in the list is representative of the consistent results we are delivering to our new and existing customers, and the growing demand for our ePRO solutions and expertise."

About invivodata inc.

invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata's solutions include comprehensive trial-support services that facilitate the collection of ePRO data, and web-based access to study data and operational reports that give researchers and sponsors visibility into study progress and improve trial efficiencies. invivodata's solution has been used in more than 200 trials and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit http://www.invivodata.com/.

For more information, contact:

invivodata inc.

Christine Tobin

Corporate Communications Specialist

(412) 390-3000, ext. 3502

ctobin@invivodata.com


'/>"/>
SOURCE invivodata inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Vigilan Recognized as One of the Fastest-Growing Private Companies in the U.S.
2. Waters SYNAPT HDMS and Xevo TQ MS Recognized for Mass Spectrometry Innovation by Industry Experts
3. Covance Recognized for Outstanding Performance by Merck & Co., Inc.
4. Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
5. Nationally Recognized Pediatric Healthcare System Chooses PureWellness for Employee Wellness Program
6. STAAR Surgicals Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification
7. Dr. Emil Chynn Featured on FOX News (WNYW-TV) Park Avenue Laser Vision Center Recognized for Creative Internet Marketing
8. Creator of PubMed Central biomedical research database recognized for outstanding citizen service
9. Verathon Inc., Recognized, Second Year Running, as Outstanding Workplace in Washington State by Washington CEO Magazine
10. China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology Institute
11. N.Y. Mets Omar Minaya Recognized at National Brain Cancer Organizations 3rd Annual Gala
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... management software and services, is proud to announce it has joined the National ... association representing the interests of chronically ill, disabled, and dying Americans of all ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, the ... launch of a free, public-facing tool for analyzing the costs of various drug ... provide comparative information to patients, providers, insurers and pharmaceutical companies about the estimated ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, a leading ... Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up ... association with efforts by the American College of Surgeons, U.S. Department of Defense, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Usually, the impending arrival of warmer weather ... those self-conscious about a double chin, this means more anxiety than elation. The cosmetic ... “For most people, a double chin is undesirable,” Dr. Goldman said, “but it seems ...
(Date:3/28/2017)... ... 28, 2017 , ... Calibration, qualification, and the appropriate level ... maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO entitled ... these requirements are explained. The challenge is to determine how to put ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Neurim Pharmaceuticals ("Neurim") and Exeltis announced today ... for Neurim,s new Rx PedPRM in Spain . ... Neurim,s paediatric prolonged-release ... children with Autism Spectrum Disorders (ASD) and neurogenetic diseases. It is ... The collaboration with Exeltis will help increase the accessibility of ...
(Date:3/29/2017)... FinancialBuzz.com News Commentary  ... The U.S. could see significant economic benefits from the expanding ... Frontier Data, the legal cannabis market is projected to create 283,422 ... the United States , as well as the economic ... that drives growth in this sector. Medical cannabis is now legal ...
(Date:3/28/2017)... LONDON , March 28, 2017 The ... at a CAGR of 13.45% from 2016 to 2023 ... Description Cancer is a chronic disease ... emerging in the cancer diagnostics market. This report is ... tumor test. The market growth is propelled due to ...
Breaking Medicine Technology: